Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M, Tsushima K, Matsumura T, Ishiwata T, Ichimura Y, Ikari J, Terada J, Tada Y, Sakao S, Tanabe N, Tatsumi K. Abe M, et al. Among authors: tsushima k. Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26566367 Free PMC article. Clinical Trial.
Clinical characteristics and risk factors of drug-induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis.
Koshikawa K, Terada J, Abe M, Iwasawa S, Sakayori M, Yoshioka K, Hirasawa Y, Kasai H, Kawasaki Y, Tsushima K, Tatsumi K. Koshikawa K, et al. Among authors: tsushima k. Thorac Cancer. 2020 Jun;11(6):1495-1502. doi: 10.1111/1759-7714.13416. Epub 2020 Apr 1. Thorac Cancer. 2020. PMID: 32237210 Free PMC article. Clinical Trial.
Risk factors for acute exacerbation following bronchoalveolar lavage in patients with suspected idiopathic pulmonary fibrosis: A retrospective cohort study.
Abe M, Tsushima K, Ishii D, Shikano K, Yoshioka K, Sakayori M, Suzuki M, Hirasawa Y, Ishiwata T, Kawasaki T, Ikari J, Terada J, Tatsumi K. Abe M, et al. Among authors: tsushima k. Adv Respir Med. 2021;89(2):101-109. doi: 10.5603/ARM.a2021.0012. Epub 2021 Apr 21. Adv Respir Med. 2021. PMID: 33881153 Free article.
357 results